(2011. november 1.) „Clonidine: clinical pharmacology and therapeutic use in pain management.”. Current Clinical Pharmacology6 (4), 280–7. o. DOI:10.2174/157488411798375886. PMID21827389.
(2000. június 1.) „A historical perspective: development of clonidine”. Best Practice & Research Clinical Anaesthesiology14 (2), 237–246. o. DOI:10.1053/bean.2000.0079.
(1999. december 1.) „A meta-analysis of clonidine for symptoms of attention-deficit hyperactivity disorder”. J Am Acad Child Adolesc Psychiatry38 (12), 1551–9. o. DOI:10.1097/00004583-199912000-00017. PMID10596256.
(2008. február 1.) „Clonidine for attention-deficit/hyperactivity disorder: I. Efficacy and tolerability outcomes.”. Journal of the American Academy of Child and Adolescent Psychiatry47 (2), 180–8. o. DOI:10.1097/chi.0b013e31815d9af7. PMID18182963.
(2008. február 1.) „Clonidine for attention-deficit/hyperactivity disorder: II. ECG changes and adverse events analysis”. Journal of the American Academy of Child and Adolescent Psychiatry47 (2), 189–98. o. DOI:10.1097/chi.0b013e31815d9ae4. PMID18182964.
(2008. február 1.) „Clonidine for Attention-Deficit/Hyperactivity Disorder: I. Efficacy and Tolerability Outcomes”. Journal of the American Academy of Child & Adolescent Psychiatry47 (2), 180–188. o. DOI:10.1097/chi.0b013e31815d9af7. PMID18182963.
(2011. június 1.) „Clonidine Extended-Release Tablets as Add-on Therapy to Psychostimulants in Children and Adolescents With ADHD” (angol nyelven). Pediatrics127 (6), e1406–e1413. o. DOI:10.1542/peds.2010-1260. ISSN0031-4005. PMID21555501. PMC3387872.
(1999) „Guanfacine, But Not Clonidine, Improves Planning and Working Memory Performance in Humans”. Neuropsychopharmacology20 (5), 460–470. o. DOI:10.1016/S0893-133X(98)00127-4. PMID10192826.
(2014. március 1.) „A review of the use of clonidine as a sleep aid in the child and adolescent population”. Clin Pediatr (Phila)53 (3), 211–6. o. DOI:10.1177/0009922813502123. PMID24027233.
(2004. március 1.) „Assessment and treatment of disturbed sleep in attention deficit hyperactivity disorder”. Expert Rev Neurother4 (2), 307–16. o. DOI:10.1586/14737175.4.2.307. PMID15853572.
Pharmacological Treatment of Attention-Deficit/HyperactivityDisorder, Handbook of Disruptive Behavior Disorders. Springer US, 221–254. o.. DOI: 10.1007/978-1-4615-4881-2_10 (1999. december 7.)
(1994. december 7.) „Clonidine for sleep disturbances associated with attention-deficit hyperactivity disorder”. J Am Acad Child Adolesc Psychiatry33 (3), 424–6. o. DOI:10.1097/00004583-199403000-00018. PMID8169189.
(2013. október 1.) „Elevated Norepinephrine may be a Unifying Etiological Factor in the Abuse of a Broad Range of Substances: Alcohol, Nicotine, Marijuana, Heroin, Cocaine, and Caffeine.”. Substance Abuse7, 171–83. o. DOI:10.4137/SART.S13019. PMID24151426. PMC3798293.
(1983) „Clonidine in mania”. Drug Development Research3 (1), 101–105. o. DOI:10.1002/ddr.430030112.
(2016. április 1.) „Role of Clonidine in Neonatal Abstinence Syndrome: A Systematic Review”. Ann Pharmacother50 (4), 301–10. o. DOI:10.1177/1060028015626438. PMID26783353.
(2013. január 1.) „Two cases of acute dexmedetomidine withdrawal syndrome following prolonged infusion in the intensive care unit: Report of cases and review of the literature”. Human & Experimental Toxicology32 (1), 107–110. o. DOI:10.1177/0960327112454896. PMID23111887.
Stähle, Helmut (2000. június 1.). „A historical perspective: development of clonidine”. Best Practice & Research Clinical Anaesthesiology14 (2), 237–246. o. DOI:10.1053/bean.2000.0079.
CG34 Hypertension - quick reference guide (PDF). National Institute for Health and Clinical Excellence, 2006. június 28. [2009. március 13-i dátummal az eredetiből archiválva]. (Hozzáférés: 2009. március 4.)
(2011. november 1.) „Clonidine: clinical pharmacology and therapeutic use in pain management.”. Current Clinical Pharmacology6 (4), 280–7. o. DOI:10.2174/157488411798375886. PMID21827389.
(2018. június 1.) „Hypertension Update: Resistant Hypertension”. FP Essent469, 20–25. o. PMID29863319.
(1999. december 1.) „A meta-analysis of clonidine for symptoms of attention-deficit hyperactivity disorder”. J Am Acad Child Adolesc Psychiatry38 (12), 1551–9. o. DOI:10.1097/00004583-199912000-00017. PMID10596256.
(2008. február 1.) „Clonidine for attention-deficit/hyperactivity disorder: I. Efficacy and tolerability outcomes.”. Journal of the American Academy of Child and Adolescent Psychiatry47 (2), 180–8. o. DOI:10.1097/chi.0b013e31815d9af7. PMID18182963.
(2008. február 1.) „Clonidine for attention-deficit/hyperactivity disorder: II. ECG changes and adverse events analysis”. Journal of the American Academy of Child and Adolescent Psychiatry47 (2), 189–98. o. DOI:10.1097/chi.0b013e31815d9ae4. PMID18182964.
(2008. február 1.) „Clonidine for Attention-Deficit/Hyperactivity Disorder: I. Efficacy and Tolerability Outcomes”. Journal of the American Academy of Child & Adolescent Psychiatry47 (2), 180–188. o. DOI:10.1097/chi.0b013e31815d9af7. PMID18182963.
(2011. június 1.) „Clonidine Extended-Release Tablets as Add-on Therapy to Psychostimulants in Children and Adolescents With ADHD” (angol nyelven). Pediatrics127 (6), e1406–e1413. o. DOI:10.1542/peds.2010-1260. ISSN0031-4005. PMID21555501. PMC3387872.
(1999) „Guanfacine, But Not Clonidine, Improves Planning and Working Memory Performance in Humans”. Neuropsychopharmacology20 (5), 460–470. o. DOI:10.1016/S0893-133X(98)00127-4. PMID10192826.
(2014. március 1.) „A review of the use of clonidine as a sleep aid in the child and adolescent population”. Clin Pediatr (Phila)53 (3), 211–6. o. DOI:10.1177/0009922813502123. PMID24027233.
(2004. március 1.) „Assessment and treatment of disturbed sleep in attention deficit hyperactivity disorder”. Expert Rev Neurother4 (2), 307–16. o. DOI:10.1586/14737175.4.2.307. PMID15853572.
(1994. december 7.) „Clonidine for sleep disturbances associated with attention-deficit hyperactivity disorder”. J Am Acad Child Adolesc Psychiatry33 (3), 424–6. o. DOI:10.1097/00004583-199403000-00018. PMID8169189.
(2013. október 1.) „Elevated Norepinephrine may be a Unifying Etiological Factor in the Abuse of a Broad Range of Substances: Alcohol, Nicotine, Marijuana, Heroin, Cocaine, and Caffeine.”. Substance Abuse7, 171–83. o. DOI:10.4137/SART.S13019. PMID24151426. PMC3798293.
(2016. április 1.) „Role of Clonidine in Neonatal Abstinence Syndrome: A Systematic Review”. Ann Pharmacother50 (4), 301–10. o. DOI:10.1177/1060028015626438. PMID26783353.
(2013. január 1.) „Two cases of acute dexmedetomidine withdrawal syndrome following prolonged infusion in the intensive care unit: Report of cases and review of the literature”. Human & Experimental Toxicology32 (1), 107–110. o. DOI:10.1177/0960327112454896. PMID23111887.
(2011. június 1.) „Clonidine Extended-Release Tablets as Add-on Therapy to Psychostimulants in Children and Adolescents With ADHD” (angol nyelven). Pediatrics127 (6), e1406–e1413. o. DOI:10.1542/peds.2010-1260. ISSN0031-4005. PMID21555501. PMC3387872.
(2013. október 1.) „Elevated Norepinephrine may be a Unifying Etiological Factor in the Abuse of a Broad Range of Substances: Alcohol, Nicotine, Marijuana, Heroin, Cocaine, and Caffeine.”. Substance Abuse7, 171–83. o. DOI:10.4137/SART.S13019. PMID24151426. PMC3798293.
Catapres- clonidine hydrochloride tablet. DailyMed , 2016. szeptember 6. (Hozzáférés: 2019. december 21.) „The pharmacokinetics of clonidine is dose-proportional in the range of 100 to 600 µg.The absolute bioavailability of clonidine on oral administration is 70% to 80%. Peak plasma clonidine levels are attained in approximately 1 to 3 hours.”
CATAPRES- clonidine hydrochloride tablet. DailyMed , 2016. szeptember 6. (Hozzáférés: 2019. december 21.) „Slowing of the pulse rate has been observed in most patients given clonidine, but the drug does not alter normal hemodynamic response to exercise. Other studies in patients have provided evidence of a reduction in plasma renin activity and in the excretion of aldosterone and catecholamines.”
CG34 Hypertension - quick reference guide (PDF). National Institute for Health and Clinical Excellence, 2006. június 28. [2009. március 13-i dátummal az eredetiből archiválva]. (Hozzáférés: 2009. március 4.)
Clonidine. Prescription Marketed Drugs. www.drugsdb.eu. [2012. március 28-i dátummal az eredetiből archiválva]. (Hozzáférés: 2022. január 21.)
worldcat.org
(2011. június 1.) „Clonidine Extended-Release Tablets as Add-on Therapy to Psychostimulants in Children and Adolescents With ADHD” (angol nyelven). Pediatrics127 (6), e1406–e1413. o. DOI:10.1542/peds.2010-1260. ISSN0031-4005. PMID21555501. PMC3387872.
